Atlas Trials

SymBio Pharmaceuticals

25 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch SymBio Pharmaceuticals

RecordFirmDate
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT (NCT07387367)SymBio Pharmaceuticals2026-03-17
A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma (NCT06761677)SymBio Pharmaceuticals2025-06-09
Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation (NCT05511779)SymBio Pharmaceuticals2022-10-14
A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection (NCT04706923)SymBio Pharmaceuticals2021-08-16
Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy Subjects (NCT04542252)SymBio Pharmaceuticals2020-11-09
Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL (NCT04354402)SymBio Pharmaceuticals2020-03-26
Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma (NCT03900377)SymBio Pharmaceuticals2019-04-01
SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors (NCT03604679)SymBio Pharmaceuticals2018-05-24
Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma (NCT03372837)SymBio Pharmaceuticals2018-01-15
Study of SyB C-1101 in Patients With Myelodysplastic Syndrome (NCT03495167)SymBio Pharmaceuticals2017-10-06

Track SymBio Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.